![Glenn Whaley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Glenn Whaley
Finanzdirektor/CFO bei
IMMUNIC, INC.
Vermögen: 142 883 $ am 31.05.2026
Profil
Mr. Glenn Whaley, CPA, is a Chief Financial Officer at Immunic, Inc., a Member at New Jersey Society of Certified Public Accountants and a Member at The American Institute of Certified Public Accountants.
Mr. Whaley was previously employed as a Chief Financial Officer by Pernix Therapeutics Holdings, Inc., a Vice President-Finance by Alvogen, Inc., and a Controller by ImClone Systems, Inc. He received his undergraduate degree from Rutgers Business School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IMMUNIC, INC. 0,07 % | 26.05.2026 | 9.551 ( 0,07 % ) | 142 883 $ | 31.05.2026 |
Aktive Positionen von Glenn Whaley
| Unternehmen | Position | Beginn |
|---|---|---|
| IMMUNIC, INC. | Finanzdirektor/CFO | 17.04.2020 |
New Jersey Society of Certified Public Accountants
 New Jersey Society of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Operates professional organization for certified public accountants | Corporate Officer/Principal | - |
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Glenn Whaley
| Unternehmen | Position | Ende |
|---|---|---|
Alvogen, Inc.
 Alvogen, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Corporate Officer/Principal | 01.03.2015 |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Comptroller/Controller/Auditor | 01.05.2011 |
| PERNIX THERAPEUTICS HOLDINGS INC | Finanzdirektor/CFO | - |
Ausbildung von Glenn Whaley
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
82
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Health Technology |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Commercial Services |
New Jersey Society of Certified Public Accountants
New Jersey Society of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Operates professional organization for certified public accountants | Commercial Services |
Pernix Therapeutics Holdings, Inc.
 Pernix Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Alvogen, Inc.
Alvogen, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Health Technology |
Rutgers Business School
 Rutgers Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunic, Inc.
 Immunic, Inc. Pharmaceuticals: MajorHealth Technology Develops oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases | Health Technology |
